| Device Classification Name |
System, Test, Automated, Antimicrobial Susceptibility, Short Incubation
|
| 510(k) Number |
K251713 |
| Device Name |
BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL) |
| Applicant |
| Becton, Dickinson and Company |
| 7loveton Cir. |
|
Sparks,
MD
21152
|
|
| Applicant Contact |
Kamisha Gray |
| Correspondent |
| Becton, Dickinson and Company |
| 7loveton Cir. |
|
Sparks,
MD
21152
|
|
| Correspondent Contact |
Kamisha Gray |
| Regulation Number | 866.1645 |
| Classification Product Code |
|
| Date Received | 06/03/2025 |
| Decision Date | 08/08/2025 |
| Decision |
Substantially Equivalent
(SESE) |
| Regulation Medical Specialty |
Microbiology
|
| 510k Review Panel |
Microbiology
|
| Summary |
Summary
|
| FDA Review |
Decision Summary
|
| Type |
Traditional
|
| Reviewed by Third Party |
No
|
| Combination Product |
No
|
Predetermined Change Control Plan Authorized |
Yes
|
|
|